Newswise — Edwin M. Horwitz, MD, PhD, recently was appointed director of Blood and Marrow Transplant (BMT) at Nationwide Children’s Hospital. Dr. Horwitz, board-certified in Pediatric Hematology/Oncology, comes to Nationwide Children’s from the Children’s Hospital of Philadelphia (CHOP). In addition to his appointment at Nationwide Children’s, Dr. Horwitz will serve as a professor in both Pediatrics and Medicine at The Ohio State University (OSU) College of Medicine.

“We are very pleased to welcome Dr. Horwitz to Nationwide Children’s Hospital,” said Timothy Cripe, MD, PhD, division chief of Hematology/Oncology/BMT at Nationwide Children’s and also a professor of Pediatrics at OSU College of Medicine. “His expertise will be invaluable to our patients and to our team, as well as expand our services in our Blood and Marrow Transplant program.”

Dr. Horwitz completed a clinical (1992) and research (1994) fellowship in Pediatric Hematology/Oncology at Washington University School of Medicine in St. Louis. He completed his residency and internship in Pediatrics (1991 and 1989, respectively) at St. Louis Children’s Hospital. Dr. Horwitz earned his doctor of medicine (1988), post doctorate in biochemistry (1985) and bachelor of arts (1981) from Indiana University.

Prior to CHOP, Dr. Horwitz was an attending physician at St. Jude Children’s Research Hospital in Memphis, Tenn., and served as a member of its Bone Marrow Transplantation, Gene Therapy, Hematopoietic Malignancies, Stem Cell Transplantation and Experimental Hematology programs. While at St. Jude, he was an associate professor of Pediatrics at the University of Tennessee, College of Medicine.

Dr. Horwtiz has held posts on a number of national and international committees in pediatric blood and marrow transplant and research. He has held editorial positions for various peer-reviewed journals, and has published nearly 200 manuscripts, book chapters, reviews and editorials.

Dr. Horwitz is married to his wife, Mary, and has a daughter, Hannah.

The Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital treats a full array of blood disorders, cancers, immune-deficiency disorders, bone marrow failure syndromes and inherited metabolic storage diseases. In addition to treatment, the division is committed to advancing both basic and clinical research in these areas. The division maintains active membership in the Children’s Oncology Group, the Therapeutic Advances in Childhood Leukemia Consoritum, the Pediatric Blood and Marrow Transplant Consortium, and is a research member of the International Blood and Marrow Transplant Registry. Hematology/Oncology/BMT works hand-in-hand with the Center for Childhood Cancer and Blood Diseases in The Research Institute at Nationwide Children’s, directed by Peter Houghton, PhD, to expand the understanding of childhood cancer and to improve strategies for its diagnosis and treatment.